OKLAHOMA CITY, June 23, 2011 /PRNewswire/ -- PD-Rx
Pharmaceuticals, Inc., a publicly held corporation, (Symbol:
PDRX.PK) today announced the purchase of the Washington EMR, an
electronic medical record, from Wilson Medical Software, LLC.
Washington EMR is the premier quality, low-cost tool for
physicians to maintain patient charts electronically. The intuitive
interface allows the physician and assistants to rapidly record
visit notes and generate prescriptions. Washington EMR computerizes
patient records through the use of standard templates that can be
edited on the fly.
PD-Rx also welcomes Mr. Eric
Wilson to the software development team. As President
of Wilson Medical Software, Mr. Wilson developed the Electronic
Medical Record software program while working closely with
physicians in California.
Mr. Wilson has decades of software experience in various
technologies including experience in the Java/Unix and Microsoft
environments, developing both front end and back end software for
medical practices.
ABOUT THE COMPANY:
PD-Rx offers pharmaceutical and management strategies to the
healthcare industry. Our management strategies focus on new
products, solid business partners, and the specialized segment of
the pharmaceutical industry. As a licensed FDA manufacturer
and packager, PD-Rx offers a full spectrum of medications and
specialized services. Our goal is to develop a matrix of cost
containment tools and products that we can merge into any
healthcare network to enhance patient care and improve managed care
organizations bottom line. We provide proprietary software,
products and prepackaged medications that are viewed by patient,
insurance payers and healthcare providers as a progressive and
responsive practice.
This press release contains "forward-looking" statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Such forward-looking statements involve known and unknown
risks and uncertainties or other factors, which may cause actual
results, performance or achievements expressed or implied by such
forward-looking statements to vary from those forecast or implied
in this release. Factors that might cause such a difference
include, without limitation, decline in demand for the company's
products or services, and the effect of general economic conditions
and factors affecting the industry.
Jack L. McCall, EVP & COO
Ph. 405-942-3040 / jlm@pdrx.com
SOURCE PD-Rx Pharmaceuticals, Inc.
